RUBY

Rubius Therapeutics, Inc
RUBY

Overview Fund Activity
Delisted

RUBY was delisted on the 6th of March, 2023.

Back to rankings

75 hedge funds and large institutions have $632M invested in Rubius Therapeutics, Inc in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 4 closing their positions.

Holders
75
Holders Change
+6
Holders Change %
+8.7%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
10
Increased
30
Reduced
14
Closed
4
Calls
$758K
Puts
$785K
Net Calls
-$27K
Net Calls Change
-$27K

Top Buyers

1
Alkeon Capital Management
1
Alkeon Capital Management
New York
$3.14M
2
BlackRock
2
BlackRock
New York
$25M
3
AllianceBernstein
3
AllianceBernstein
Tennessee
$22.1M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$61.4M
5
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$11.4M

Top Sellers

1
EC
1
EcoR1 Capital
California
$2.04M
2
CAM
2
Cormorant Asset Management
Massachusetts
$3.86M
3
Ameriprise
3
Ameriprise
Minnesota
$672K
4
Jennison Associates
4
Jennison Associates
New York
$3.41M
5
Millennium Management
5
Millennium Management
New York
$469K
Name Market Value Shares Shares
Change 		Shares
Change %
RE
76
RBC Europe
United Kingdom
– – -635 Closed
BFEC
77
Benjamin F. Edwards & Company
Missouri
– – -525 Closed
PCM
78
Prelude Capital Management
New York
– – -352 Closed
O
79
OrbiMed
New York
– – – –
CG
80
Cutler Group
California
– – – –
IA
81
IFP Advisors
Florida
– – – –
CFGS
82
Concourse Financial Group Securities
Alabama
– – – –
PHK
83
Point72 Hong Kong
Hong Kong
$0 35 +35 New
1 2 3
4